Financial statements Apteka Prima
Balance sheet data of APTEKA PRIMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 325 460,04 | 448 121,02 | 554 961,48 | 736 933,61 | 803 673,87 | 1 009 619,65 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 1 279,00 | 47 879,00 |
| B. Current assets | 325 460,04 | 448 121,02 | 554 961,48 | 736 933,61 | 802 394,87 | 961 740,65 |
| C. Share capital contributions (basic funds) | 0,00 | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 325 460,04 | 448 121,02 | 554 961,48 | 736 933,61 | 803 673,87 | 1 009 619,65 |
| A. Equity | 126 454,69 | 184 239,50 | 239 184,73 | 297 003,05 | 300 200,91 | 452 578,55 |
| B. Liabilities and provisions for liabilities | 199 005,35 | 263 881,52 | 315 776,75 | 439 930,56 | 503 472,96 | 557 041,10 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 199 005,35 | 263 881,52 | 315 776,75 | 439 930,56 | 503 472,96 | 557 041,10 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.